Literature DB >> 19628422

Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer.

Avaniyapuram Kannan Murugan1, Nguyen Thi Hong, Tran Thi Kim Cuc, Nguyen Chan Hung, Arasambattu Kannan Munirajan, Masa-Aki Ikeda, Nobuo Tsuchida.   

Abstract

Oral squamous cell carcinoma is the sixth most common cancer in the world and the seventh most common cancer in Vietnam. The RAS and PI3K-AKT signaling pathways play an important role in oral carcinogenesis. Our previous study on PI3K signaling pathway showed the absence of PIK3CA and PTEN gene mutations in Vietnamese oral cancer. We thus hypothesized that the RAS could be more likely activated as an upstream effector. However, the status of RAS mutations in Vietnamese oral cancer had not been studied. In the present study, Fifty six primary tumor DNA samples were screened for mutations of hot spots in exons 1 and 2 of H-RAS and a part of the samples for exon 7 of ERK2 gene in which we previously reported a mutation in an OSCC cell line. The H-RAS mutations were detected in 10 of 56 tumors (18%). Two novel mutations were found, one was an insertion of three nucleotides (GGC) between codons 10 and 11 resulting in in-frame insertion of glycine (10(Gly)11) and the other was a missense mutation in codon 62 (GAG>GGG). We also found T81C single nucleotide polymorphism in 12 of 56 tumors (22%) and there was no mutation in exon 7 of ERK2 gene. The H-RAS mutation incidence showed significant association with advanced stages of the tumor and also with well-differentiated tumor grade. Our study is the first to report H-RAS mutation from Vietnamese ethnicity, with two novel mutations and relatively high incidence of H-RAS mutations. The results suggest that RAS is an important member in the PI3K-AKT signaling and could play an important role in the tumorigenesis of oral carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628422     DOI: 10.1016/j.oraloncology.2009.05.638

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  13 in total

1.  An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas.

Authors:  Yusuke Zushi; Mako Narisawa-Saito; Kazuma Noguchi; Yuki Yoshimatsu; Takashi Yugawa; Nagayasu Egawa; Masatoshi Fujita; Masahiro Urade; Tohru Kiyono
Journal:  Am J Cancer Res       Date:  2011-08-18       Impact factor: 6.166

2.  New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.

Authors:  Lucy F Chen; Ezra E W Cohen; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2010-04-20       Impact factor: 12.531

Review 3.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

4.  Single nucleotide polymorphisms of mucosa-associated lymphoid tissue 1 in oral carcinoma cells and gingival fibroblasts.

Authors:  Go Oyama; Toshiaki Midorikawa; Yasutaka Matsumoto; Mayu Takeyama; Kenji Yamada; Takaomi Nozawa; Masako Morikawa; Kazushi Imai
Journal:  Odontology       Date:  2012-07-03       Impact factor: 2.634

5.  The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.

Authors:  Megan E Arrington; Brenda Temple; Antje Schaefer; Sharon L Campbell
Journal:  J Biol Chem       Date:  2020-07-07       Impact factor: 5.486

6.  Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients.

Authors:  Rashid Mir; Imtiyaz Ah; Jamsheed Javid; Mariyam Zuberi; Sameer Guru; Masroor Mirza; Shazia Farooq; Prasant Yadav; Prakash C Ray; Naresh Gupta; Alpana Saxena
Journal:  World J Oncol       Date:  2015-04-12

7.  Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer.

Authors:  Junhao Yin; Xiaoli Zeng; Zexin Ai; Miao Yu; Yang'ou Wu; Shengjiao Li
Journal:  BMC Med Genomics       Date:  2020-06-22       Impact factor: 3.063

Review 8.  Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

9.  Study on association between H-ras gene polymorphism and gastric adenocarcinoma risk.

Authors:  Masoumeh Rostami; Zahra Kalaei; Mohamad Amin Pourhoseingholi; Mehdi Kadivar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.

Authors:  Elisabetta Flex; Mamta Jaiswal; Francesca Pantaleoni; Simone Martinelli; Marion Strullu; Eyad K Fansa; Aurélie Caye; Alessandro De Luca; Francesca Lepri; Radovan Dvorsky; Luca Pannone; Stefano Paolacci; Si-Cai Zhang; Valentina Fodale; Gianfranco Bocchinfuso; Cesare Rossi; Emma M M Burkitt-Wright; Andrea Farrotti; Emilia Stellacci; Serena Cecchetti; Rosangela Ferese; Lisabianca Bottero; Silvana Castro; Odile Fenneteau; Benoît Brethon; Massimo Sanchez; Amy E Roberts; Helger G Yntema; Ineke Van Der Burgt; Paola Cianci; Marie-Louise Bondeson; Maria Cristina Digilio; Giuseppe Zampino; Bronwyn Kerr; Yoko Aoki; Mignon L Loh; Antonio Palleschi; Elia Di Schiavi; Alessandra Carè; Angelo Selicorni; Bruno Dallapiccola; Ion C Cirstea; Lorenzo Stella; Martin Zenker; Bruce D Gelb; Hélène Cavé; Mohammad R Ahmadian; Marco Tartaglia
Journal:  Hum Mol Genet       Date:  2014-04-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.